Arrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ

Similar documents
Implications of the new diagnostic criteria for ARVC

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

FANS ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) Investigation Protocol

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

Arrhythmogenic Right Ventricular Cardiomyopathy. Europace June 28,2011

BMR Medicine. Case Study YOUNG PATIENT WITH RECURRENT PRESYNCOPE: A CASE REPORT

Benign RVOT Ectopy and RV dysplasia

Unusual Serial Electrocardiographic Changes which Progressed to Arrhythmogenic Right Ventricular Cardiomyopathy

Name of Presenter: Marwan Refaat, MD

Clinical phenotypes associated with Desmosome gene mutations

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

Biventricular Arrhythmogenic Cardiomyopathy: A New Paradigm?

Prevention of Sudden Death in ARVC

INTRODUCTION. left ventricular non-compaction is a sporadic or familial cardiomyopathy characterized by

Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy

Left-Dominant Arrhythmogenic Cardiomyopathy

Clinical aspects of Arrhythmogenic Cardiomyopathies

Aνταλένα Τσατσοπούλου ΝΙΚΟΣ ΠΡΩΤΟΝΟΤΑΡΙΟΣ ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ - ΝΑΞΟΣ. Arrhythmogenic Cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Analysis based on six cases

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Arrhythmogenic Right Ventricular Dysplasia: An Under-recognized Form of Inherited Cardiomyopathy

Impact of the Revision of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Task Force Criteria on Its Prevalence by CMR Criteria

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

Arrhythmogenic right ventricular dysplasia: a rare case report from tribal zone of Central India

Arrhythmogenic right ventricular

27-year-old professionnal rugby player: asymptomatic

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Cardiomyopathy. Mechanisms An Update. Professor of Medicine (Cardiology) University of Ottawa

Pathobiology of arrhythmogenic right ventricular cardiomyopathy Paediatric

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Risk Factors for Sudden cardiac Death

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Arrhythmogenic right ventricular cardiomyopathy/dysplasia

Sudden cardiac death: Primary and secondary prevention

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

Is it HF secondary to rheumatic heart disease???

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

ΜΥΟΚΑΡΔΙΟΠΑΘΕΙΕΣ. Ανεξήγητη βραδυκαρδία µε ή χωρίς διαταραχές κολποκοιλιακής αγωγής: τι µπορεί να κρύβει? ΕΦΗ Ι. ΠΡΑΠΠΑ Καρδιολόγος

Tachycardia-induced heart failure - Does it exist?

XVth Balkan Congress of Radiology Danubius Hotel Helia, October 2017, Budapest, Hungary

Ablative Therapy for Ventricular Tachycardia

CLINICAL PROFILE OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (ARVC) Lubna Noor, Yasir Adnan, Mohammad Faheem, Shahab Ud Din, 5 6 7

Breed specificities of Canine Dilated Cardiomyopathy Dr. Gerhard Wess

Cardiomyopathies. Andre Keren, MD

ECG Underwriting Puzzler Dr. Regina Rosace AVP & Medical Director

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Genetic Cardiomyopathies

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

Office ECG Interpretation

Το ΗΚΓ στις Μυοκαρδιοπάθειες και στην Περικαρδίτιδα

Πρόληψη του ΑΚΘ σε ασθενείς με μη-ισχαιμική μυοκαρδιοπάθεια:

Arrhythmogenic right ventricular dysplasia masquerading as right ventricular outflow tract tachycardia

6/19/2018. Background Athlete s heart. Ultimate question. Applying the International Criteria for ECG

Cardiac MRI: Cardiomyopathy

Advances in Ablation Therapy for Ventricular Tachycardia

Keywords: Arrhythmogenic right ventricular dysplasia/cardiomyopathy; Naxos disease; Cell adhesions;

Φαρμακεσηική αγωγή ζηις ιδιοπαθείς κοιλιακές αρρσθμίες. Άννα Κωζηοπούλοσ Επιμελήηρια Α Ωνάζειο Καρδιοτειροσργικό Κένηρο

Urgent VT Ablation in a Patient with Presumed ARVC

Distribution of biventricular disease in arrhythmogenic cardiomyopathy: an autopsy study

Definition and classification of the cardiomyopathies. Georgios K Efthimiadis Ass Prof of Cardiology

The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.s358l mutation in TMEM43

HYPERTROPHIC CARDIOMYOPATHY RISK STRATIFICATION WHAT IS NEW?

Declaration of conflict of interest. I have nothing to disclose.

Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

at least 4 8 hours per week

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Ventricular fibrillation and sudden death may occur in

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

Clinical Genetics in Cardiomyopathies

Update in Cardiomyopathies: Their New Classifications and Importance of Mixed Phenotypes

Paroxysmal Supraventricular Tachycardia PSVT.

Epicardial VT Ablation The Cleveland Clinic Experience

10.5 Restrictive Cardiomyopathy

Normal ECG And ECHO Findings in Athletes

Cardiomyopathy: The Good, the Bad.and the Insurable?

CME Article Brugada pattern masking anterior myocardial infarction

The Brugada Syndrome: An Easily Identified and Preventable Cause of Sudden Cardiac Death

Heart Rhythm Disorders. How do you quantify risk?

Please check your answers with correct statements in answer pages after the ECG cases.

LVH GREY ZONE OF HYPERTROPHIED VENTRICLES

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

HCM GUIDELINES ESC 2014 HYPERTROPHIC CARDIOMYOPATHY ASYMPTOMATIC PATIENT

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ

Electroanatomic Substrate and Outcome of Catheter Ablative Therapy for Ventricular Tachycardia in Setting of Right Ventricular Cardiomyopathy

Use of Biventricular Pacing in Arrhythmogenic Right Ventricular Cardiomyopathy with Disarticulated Right Ventricle

Return to Basics. ECG Rate and Rhythm. Management of the Hospitalized Patient September 25, 2009

La valutazione dell atleta: è una strategia salva-vita e costo-efficace?

Ventricular arrhythmias

Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy

Return to Basics. Normal Intervals & Axes. ECG Rate and Rhythm

ECG Workshop. Nezar Amir

Non-Cardiac Sudden Death in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy

Transcription:

Arrhythmogenic Cardiomyopathy cases Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ

Definition ARVD (Arrhythmogenic Right Ventricular Dysplasia) Progressive loss of RV myocardium and its replacement with fibrofatty tissue Marcus F et al, Circulation 1982 ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy) This disease falls within the spectrum of the nonischemic cardiomyopathies classified by the World Health Organization in 1994 ACM (Arrhythmogenic Cardiomyopathy) McKenna et al, Br Heart J 1994 the more recent recognition of left-dominant and biventricular forms has led to adoption of the broader term Sen Chowdhry et al, Ann Rev Med 2010

1/1000-1/ 5000 Second to fifth decade of life Uncommon to first develop sighs and symptoms of ACM after the age of 70 yo Asimaki A Canadian Journal of Cardiology 2015

Pathology Myocyte degeneration and fibrosis, with or without fat (the most important histopathological indicator of the disease) Myocardial atrophy is a genetically determined process that occurs progressively with time (periodic acute bursts-hot phases) Starts from the epicardium and extends to the endocardium to become transmural Progressive wall thinning (aneurysms) predominantly at the triangle of dysplasia

Inheritence Autosomal dominant pattern Incomplete penetrance Penetrance is definition dependent Variable expression Marked intrafamilial phenotype diversity

Desmosome Cristina Basso, Lancet 2009 Asimaki A Canadian Journal of Cardiology 2015

Non desmosomal gene mutations Ryanodin receptor (Ca release from SR) Juvenile SD and effort-induced polymorphic VT Transmembrane protein 43 (Canada) Inner nuclear membrane Premature SD and severe HF Phospholamban First found in DCM Transforming Growth factor 3β (TGF3β) Play a role in cardiac inflammation and fibrosis

The desmosomes are remodelled and there is abnormalities to cell to cell adhesion But is pathogenesis related only to these abnormalities?

Depressed plakoglobin (γ catenin) to cell to cell junctions Cellular redistribution of plakoglobin to the intracellular and nuclear pools Hallmark for ACM β catenin structural protein and signalling molecule can not replace γ catenin at desmosomes Redistribution of plakoglobin may interfire with activity of β catenine

Zorzi A et al 2016

huhu

1 st case Female 60 yo Right Heart Failure work up Anemia ESR 100 mm

Background 26/10/2008 Sick sinus syndrome (holter 4,6 sec/ syncope) PCM 4/8/2010 VT LBBB (hemodynamic instability-syncope) electric sock CA 80% LCx PCI 19/4/2012 RHF hospitalization (1 st diagnosis) right pleural fluid Diagnosis of pulmonary embolism? (lung scintigraphy) 3/3/2017 AHEPA cardiomyopathy lab

Lopresor 100mg (50 mg bid) Lasix 40mg (od) Aldactone 25 mg (od) Sintrom

SD SD Ca Ca 50 37 40 AF Narcotics

Holter 3 NSVT episodes PVCs= 2067/24ωρο

CT thorax

Immune blood test normal Gatroscopy- Colonoscopy normal Right heart catheterization and Myocardial Biopsy

ventriculography

Proband 4 major criteria (- ) T waves V1, V2, V3 (repolarization abnormalities) VT LBBB (superior axis) (arrhythmias) RV aneurysm (ECHO and ventriculography) RVOT PLAX 4,5 cm Residual myocytes <60% (tissue) Definite diagnosis

Corrado et all, Circulation. 2015

Breast Ca One month later

2 nd case Boy 15 yo 24 hours fever Angina (-) NYHA I Syncope (-) Palpitations (-) Kickboxing (5 months)

AHEPA

Holter

probnp 322 pg/ml Troponine 7 pg/ml Immunological tests (-) Carvedilol 6,25 mg 1x2 Ramipril 5 mg 1/2x1 Eplerenone 25 mg 1/2x1

Proband major criteria Residual myocytes<60% with fibrous replacement of the RV free wall myocardium in 1 sample, with or without fatty replacement of tissue on endomyocardial biopsy (tissue characterization) minor criteria NSVT (arrhythmias) Negative T waves (V4,V5,V6) (repolarization abnormalities) 1 major + 2 minor definite diagnosis

ICD (30/5/2017) ATP therapy due to VT episode (4/10/2017)

Father Normal ECG Normal ECHO No PVCs

Mother NSVT holter Normal ECHO No ECG criteria

Diagnosis of familial ARVC (in a context of proven ARVC/D in a first-degree relative) T-wave inversion in right precordial leads V1, V2, and V3 in individuals over the age of 14 years Late potentials by signal-averaged ECG (SAECG) Ventricular tachycardia of left bundle-branch block morphology on ECG, Holter monitor, or during exercise testing, or 200 premature ventricular contractions in 24 hours Either mild global dilatation or reduction in RV ejection fraction with normal LV or mild segmental dilatation of the RV, or regional RV hypokinesis

Mother 1 criteria NSVT Holter Definite diagnosis

LDAC ACM versus late stage ACM with LV involvement LDAC phenotype Ventricular arrhythmia of RBBB morphology Additional LBBB phenotype Septal LGE Negative T waves in inferolateral leads Late stage ACM Ventricular arrhythmia of LBBB morphology Multifocal arrhythmia less frequently The septum is generally spared Negative T waves in right precordial leads Chowdhry SS,et al JACC 2008

LDAC ACM versus DCM Midwall enhancement is observed in both, but subepicardial distribution raises suspicion of ACM Predisposition to ventricular arrhythmia that exceeds the degree of morphological abnormality and systolic impairment Myocyte loss with fibrofatty replacement on histology Chowdhry SS,et al JACC 2008

2-12% desmoplakin mutation (ACM cases) More often associated with a predominant LV phenotype or biventricular involvement Desmoplakin mutations correlates with a high arrhythmic risk Non- missense mutations are specifically associated with left dominant forms Castelletti S et al, Int J Cardiol 2017

Take home messages Arrhythmogenic Cardiomyopathy - Classic ACM - Left dominant ACM - Biventricular ACM Diagnosing criteria are focusing on RV predominance Look at the ECGs Look at the families

Many Thanks